| Old Articles: <Older 53861-53870 Newer> |
|---|
 |
The Motley Fool
December 1, 2011
John Grgurich |
Pfizer Losing Lipitor Patent: What Investors Need to Know The patent ends today.   |
The Motley Fool
December 1, 2011
Rich Smith |
salesforce.com Makes a Sales Pitch Does it make sense? One analyst thinks not. |
The Motley Fool
December 1, 2011
David Meier |
Why I Am Buying MAKO Surgical MAKO Surgical is changing orthopedic surgery, one robot at a time. |
On Wall Street
December 1, 2011
Elizabeth Wine |
Best Bets for 2012 All analysts acknowledge the whipsaw volatility of the stock market, and many are looking to income generators. Most are fans of dividend-paying stocks from companies with strong balance sheets. |
The Motley Fool
December 1, 2011
Evan Niu |
Has lululemon's Good Problem Turned Bad? lululemon athletica reports earnings, and now some think it has too much inventory instead of not enough. |
The Motley Fool
December 1, 2011
Alexander Crawford |
Solar Trade War: Will These Clean Energy Stocks Weather the Storm? Do you think these companies will outperform despite the possible trade war? |
The Motley Fool
December 1, 2011
Beyers & Koppenheffer |
What Really Killed MF Global An amped-up business model is taking blame it doesn't deserve. |
The Motley Fool
December 1, 2011
Alyce Lomax |
2 Retail Stocks to Avoid These two retail stocks are way out of fashion. |
The Motley Fool
December 1, 2011
Evan Niu |
An Insider Buys Apple Disney CEO and new Apple director Bob Iger buys $1 million of Apple stock. |
The Motley Fool
December 1, 2011
Dan Radovsky |
AT&T Lashes Back at FCC AT&T calls the FCC report "one-sided" and says it "lacks all credibility." |
| <Older 53861-53870 Newer> Return to current articles. |
